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Polymorphism and antigenic variation are important biological survival strategies of malaria parasites 
determining the episode, outcome and implications of treatment interventions. In P. falciparum, 
polymorphic antigens are associated with the asexual blood-stage; merozoite surface protein 2 (MSP2). 
The MSP2 genes have been invaluable in post-treatment discrimination of parasite resurgence from 
new infection, especially in high transmission areas. We performed polymerase chain reaction (PCR) on 
DNA extracted from blood samples of 141 malaria-infected infants, followed by restriction fragment 
length polymorphism (RFLP) of PCR products. The findings showed multiplicity of infections of single 
to six infections with an average of 2.58 infections per patient. Single infections of either 3D7 or FC27 
allelic families of the MSP2 gene occurred in 51 patients (50.5%) out of all PCR-RFLP successful 
samples (n = 101). Out of 15 (10.6%) follow up samples with resurgent parasitaemia, 3 (20%) samples 
had recrudescent infections while 12 (80%) had variable results. Our findings provide an insight on the 
prevalence of the genetic determinants of suphadoxine-pyrimethamine (SP) resistance in Mlimba during 
the study period, and in the face of rapidly spreading resistance, calls for the periodic surveillance in 
order to timely detect early warning signal of the deteriorating SP cure rate. 
 





Following widespread of chloroquine (CQ)-resistant 
Plasmodium falciparum strains, which evolved from early 
1950s in the country, Tanzania changed and adopted the 
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first-line drug and amodiaquine (AQ) as second-line drug 
against uncomplicated malaria in August 2001.  During 
the same period, SP was also approved as first or 
second-line antimalarial drug by most African countries 
for treatment of uncomplicated malaria (Sibley et al., 
2001). The basis for complimentary SP use relies on its 
activity against CQ-resistant strains, ease of 
administration, tolerability and low cost compared to other 
available antimalarial drugs (Foster, 1994; Fevre and 
Barnish, 1999). However, subsequent reports of rapid 
spread of resistance against SP in Tanzania 
(Mutabingwa et al., 2001) and elsewhere in Africa 
(Jelinek et al., 2002; Kublin et al., 2002; Bwijo et al., 
2003) has created a debate on its persistent use as first-
line drug against malaria parasite in the region. 
 




Polymorphism and antigenic variation are common 
survival strategies of the malaria parasites in human 
populations (Felger et al., 1999). Individuals living in 
areas where P. falciparum is endemic experience 
numerous episodes of infection with symptoms and 
outcome varying depending on a combination of parasite 
factors (the structure of the parasite population and the 
survival strategies of the parasite) and host factors 
reflected by the immune response, and the implications 
of interventions (Hoffman et al., 2001). Polymorphic 
antigens have been described in several parasite life 
cycle stages but are particularly a feature of the antigens 
associated with the surface of the asexual blood-stage 
merozoites, merozoite surface protein 2, MSP2 (Scythe 
et al., 1990; Felger et al., 1999). These parasite surface 
proteins are polymorphic and have antigenic role to the 
parasite survival (Aubouy et al., 2003).  
MSP2 is a 45- to 52-kDa integral membrane 
glycoprotein encoded by a single-copy gene, and is 
anchored on the surface of the merozoite by a 
glycosylphosphatidylinositol (GPI) moiety. MSP2 
sequences usually are assigned to one of two families, 
FC27 and IC-1/3D7, on the basis of the non-repetitive 
sequences (Fenton et al., 1991; Smythe et al., 1991; 
Snewin, 1991). Sequencing of MSP2-alleles and PCR-
RFLP from a large number of parasite isolates from 
different geographical locations has shown a virtually 
dimorphic structure of the molecule (Felger et al., 1999). 
This antigenic diversity of the parasites renders the highly 
polymorphic MSP2 gene suitable as a marker for 
genotyping of P. falciparum and enumerating multiple 
concurrent infections in blood samples and distinguishing 
individual alleles (Scythe et al., 1990; Felger et al., 1999; 
Aubouy et al., 2003).  
Characterisation of the polymorphic MSP2 antigen has 
been used to establish whether a parasitaemia observed 
after treatment is caused by a recrudescence of resistant 
parasites or by a new infection (Babiker et al., 1994; Al-
Yaman et al., 1997). This could be helpful in in vivo tests, 
particularly in areas with a considerable amount of 
transmission where, after a certain time, it is impossible 
to distinguish between recrudescence and new infection. 
Genotyping of field isolates is useful in detecting not only 
the multiplicity of mixed clone infections, but also aids in 
studying infection dynamics and finding markers for 
virulence and drug resistance (Felger et al., 1999). 
Genotyping of the MSP2 gene is achieved by a 
combination of Polymerase Chain Reaction (PCR) and 
Restriction Fragment Length Polymorphism (RFLP) 
(PCR-RFLP) analyses. Using PCR-RFLP approach, 
Babiker et al. (1994) and Hill and Babiker (1995) showed 
a multiplicity of infections ranging between 1 – 6 parasite 
clones per infection in patients of Michenga, an area 
about 155 km east of Mlimba along Kilombero valley in 
Tanzania. In the present study we use PCR-RFLP 
approach to determine the multiplicity of infections 





endemic area of Mlimba division of Kilombero district in 
Morogoro, Tanzania.  
 
 
MATERIALS AND METHODS 
 
Study area  
 
The study was conducted at Ifakara Health Research and 
Development Center (IHRDC) situated at Ifakara Town in Kilombero 
District, Morogoro, Tanzania. Samples used in this study were 
collected by the IHRDC from Mlimba, an area about 150 km away, 
south-east of Ifakara. Mlimba lies along Kilombero River where 
falciparum malaria is endemic with perennial transmission. This 
area is among nine sentinel sites for National Malaria Control 
Program in Tanzania since 1997 and its human population 
dynamics has closely been monitored on a monthly basis by the 






The ethical clearance was obtained from both National Institute for 
Medical Research (NIMR) and IHRDC Institutional Ethics 
Committee authorities. We obtained informed consent from parents 
or guardians of participating children. Blood samples were collected 
between January and August 2002. About 172 patients consisting 
of males and females with uncomplicated falciparum malaria and 
aged 6 – 69 months were initially recruited in this study using the 
WHO-set criteria described by the MIM/TDR guidelines for 
protocols involving molecular markers for drug resistance and 
multiplicity of infections (2001). SP was given as a single dose on 
day 0 equivalent to 25 mg/kg body weight based on sulphadoxine 
component (WHO, 2001). Fractions of the tablets were rounded up 
to the nearest quarter. Thirty-one patients were either excluded 
from the study due to failure to comply with criteria for participating 
in the study or were lost during follow up. Consequently 141 blood 
samples were available and were used in molecular analysis.  
 
 
Sample collection  
 
Blood samples for parasite genotyping were collected on filter 
paper (3MM Whatman), labeled and identified, and kept in a dry 
clean container with desiccant for a minimum of 3 h to dry. Dry filter 
paper blood samples were stored at room temperature until when 
were analysed. The follow-up samples were obtained at days 3, 7 
and day 14 after SP treatment. Additional follow-ups were done at 
any other day if the child was unwell. During all these visits, finger-
prick blood was obtained for microscopy and genotyping.  
 
 
DNA Extraction and PCR analysis 
 
P. falciparum DNA was extracted from blood collected on 3MM 
Whatmann filter paper by chelex method as previously described 
(Plowe et al., 1995). The extracted DNA from each sample was 
used immediately for PCR and the remaining portion was kept 
frozen at -20ºC. The DNA was amplified in two steps, the primary 
and nested PCR as described by Foley et al. (1992), Duraisingh et 
al. (1998) and Felger et al. (1999). Primers sequences and PCR 
conditions are shown in Table 1. Amplification was repeated at 
least twice before the sample was declared negative. The primary 
and secondary PCR reactions were done in 25 µl and 30 µl final 
volumes, respectively, and the final volume contained 250 nM 
primers,  1.5 mM  MgCl2,  125 µM  of  each deoxyribonucleoside tri- 
 




Table 1. Table of PCR primer sequences and reaction conditions for the nested amplification of MSP2 gene. 
 
Primer    Primer sequence PCR conditions 
5’ GAGGGATGTTGCTGCTCCACAG 3’ Outer     S2 
              S3 5’ GAAGGTAATTAAAACATTGTC 3’ 
94oC-3 min, 94oC-30 s,  
42oC-60 s, 65C-2 min, x30, 72oC-3 min, 4oC-hold 
5’ GAGTATAAGGAGAAGTATG 3’ Inner     S1 
             S4 5’ CTAGAACCATGCATATGTCC 3’ 
94oC-30 s, 50 oC-60 s,  
72oC-2 min, x30, 72oC-3 min, 4oC-hold 
 




phosphate (dNTPs) and 0.02 U/µl Taq polymerase (Promega). In 
primary reaction mixture, 5 µl of template DNA was used while in 
the nested PCR reaction; aliquots of 2 µl of primary PCR products 
were added. For controls, purified genomic DNA from HB3, 3D7, 
7G8 and V1S laboratory strains were used. 
 
 
Restriction enzyme digestion 
 
The MSP2 nested PCR amplicons were subjected to site-specific 
restriction enzyme digestion using HinfI enzyme (New England 
Biolabs). Restriction digestion was performed in 1.5 ml tubes as per 
manufacturer's recommendations.  Essentially 25 l reaction 
volume was used containing 17 l aliquot of reactants from master 
mix (1x restriction buffer, restriction enzyme and sterile water 
[Sigma chemicals Co. ST Luis USA]) and 8 l of PCR product. The 
reaction mixture was overlaid with mineral oil and capped to 
prevent evaporation. The restriction digests were incubated 
overnight at 370C. To stop the reaction, 5 l of 6x loading buffer 
(Sigma chemicals Co. ST Luis USA) was added and the reaction 






Gel electrophoresis was performed on nested PCR products to 
confirm the presence of PCR amplicons of interest. These were 
electrophoresed on 2% agarose gels in 100 ml of 1x TBE (100mM 
Tris, 100 mM Borate and 5 mM EDTA) solution. The gels were 
stained with 0.5 g/ml ethidium bromide final concentration and 
DNA visualized by UV transillumination. Fragments obtained were 
compared by size with reference to 1 Kb DNA ladder (Gibco BRL 
Life Technologies).   
On the other hand, polyacrylamide gel electrophoresis was 
performed on restriction digests as described by Sambrook et al. 
(1989). This was done on 10% polyacrylamide gel (PAA) using 1x 
TBE and 1Kb DNA ladder (Gibco BRL Life Technologies).  
Electrophoresis was carried out at a constant voltage of 11.25 V/cm 
gel for 2.30 h and the gel stained with ethidium bromide and 





The PCR-RFLP data was analysed using the EPI Info Version 6.04 
epidemiological software (Centre for Disease Control and 
Prevention, Atlanta, GA, USA). The prevalence of each allelic family 
in the MSP2 gene was calculated as the percentage of baseline 
(D0) samples containing alleles of that particular family (Aubouy et 
al., 2003). The distribution of specific families was estimated as the 
percentage of fragments assigned to one family within the overall 
number of fragments. The multiplicity of infections and parasite 
diversity was found by counting and comparing the number of 
different alleles within and between the two allelic families basing 
on the different restriction fragment sizes (Felger et al., 1999). In 
this context, multiplicity of infection (MOI) was defined as the 
number of genotypes per infection and was calculated as the 
highest number of genotypes at the MSP2 locus of the parasite 
DNA and was the basis for establishment of parasite diversity 





PCR amplification of the MSP2 gene 
 
From clinical evaluation (clinical data provided by IHRDC) 
a total of 172 children with  uncomplicated malaria were 
recruited into the study and treated with SP. Out of these 
recruited patients, 141 (82%) successfully completed the 
study. Data from 31 (18%) patients who could not 
complete the 14 days follow-up were excluded from 
analysis. Treatment failure was depicted in 15 (10.6%) 
patients of which, 6.7% was early treatment failure and 
3.9% was late treatment failure. Adequate clinical 
response was observed in 126 (89.4%) of patients.  
Successful PCR amplification of MSP2 gene was 
achieved in 125 (88.7%) out of 141 samples analysed 
while 16 (11.3%) samples were PCR negative. Figure 1 
and 2 depicts the PCR amplification of the MSP2 gene 
using S1/S4 primers of some representative samples. 
The band sizes of PCR amplicons ranges between 378 
and 740 bp.   
  
 
Detection of multiplicity of P. falciparum infection by 
RFLP analysis 
 
The number of infecting genotypes in an isolate 
(multiplicity of infection) was detected by restriction 
digestion (RFLP) of the MSP2 gene (Beck et al., 1997) 
using HinfI (New England Biolabs) followed by PAA gel 
(10%) analysis. Restriction digestion was successful in 
81% (101/125) of PCR products. Figure 3 depicts 
representative restriction fragment patterns of the MSP2 
gene obtained. Products contained conserved fragments 
of sizes 115 and 137 bp for FC27-type alleles and 
variable fragments ranging from 150 – 378 bp. For 3D7-
type alleles, conserved fragments of 70 and 108 bp and 
variable  fragments  of  sizes  ranging from 250 to 550 bp
 






Figure 1. MSP2 gene PCR products run on 2% agarose gel. Number 86 and 96 indicate negative DNA 
samples. NT = negative control sample. PCR band sizes lies between 378 and 740 bp. An arrow indicates 





Figure 2. MSP2 gene PCR products run on 2% agarose gel. Number 114 to 126 indicate positive 
DNA samples. VIS = positive control and NT = negative control. Samples number 115, 120 and 125 




were obtained (Figure 3 and 4).   
Furthermore, considering individual allelic families 
(Table 2), 75 (74.3%) patients carried 3D7 allelic family 
genotypes in which 57 (56.4%) occurred as single alleles. 
Double 3D7 allelic family genotypes were detected in 14 
(13.9%) while 3 (3.0%) had triple 3D7 genotypes. Only 1 
(1.0%) possessed quintuple genotypes. On the other 
hand, the FC27 allelic family occurred in 62 (61.4%) 
infants in which 47 (46.7%) were single genotypes and 
12 (11.9%) were double genotypes. Two (2.0%) of the 
infants had triple FC27 genotypes and 1 (1.0%) had 
quadruple genotypes (Table 2). In this particular study, 
multiplicity of infections of above three infections per 
patient was defined as multiple infections.  
Overall multiplicity of infections of the MSP2 genotypes 
of the P. falciparum 3D7 and FC27 allelic families from 
Mlimba are depicted in Table 3. It was observed that, 51 
(50.5%) out of 101 infants carried single infection of 
either of the two allelic families. Double infection occurred 
in 32 (31.7%)  infants. Twelve (11.9%) infants carried trip-  
 






Figure 3. MSP2 RFLP products on 10% PAA gel. Lanes 122 and 123 represent the 3D7 and FC27 allelic 
families, respectively. The patterns of fragment sizes are 70, 108, 290 bp for 3D7 and 115, 137, 260 for FC27 in 
that order. Lanes 119 and 126 indicate degraded DNA fragments.  
 
 
Table 2. Frequency of different MSP2 alleles of P. falciparum found in 101 PCR-RFLP successful samples of infants from Mlimba. 












3D7 26 (25.7%) 57 (56.4%) 14 (13.9%) 3 (3.0%) 1 (1.0%) 101 (100.0%) 
FC27 39 (38.6%) 47 (46.5%) 12 (11.9%) 2 (2.0) 1 (1.0%) 101 (100.0%) 
Total 65 104 36 5 2 212 
 
(Allele)' = Not of that particular allelic family but the counterpart (Allelic family complement) 






Figure 4. A PAA representative gel for MSP2 PCR-RFLP. 
Restriction patterns in lanes 2, 5 and 12 represent samples with 
mixed genotypes in a single patient defining the multiplicity of 




le infection and six (5.9%) had multiple infections. 
Multiplicity of infection ranged from 1 to 6 infections per 
blood sample with mean multiplicity of 2.58 per infection  
Table 3. Overall frequency of multiplicity of infections of the MSP2 
genotypes of the P. falciparum 3D7 and FC27 allelic families from 
Mlimba.  
 
Infections Frequency Percent Cumulative 
Frequency 
Single 51 50.5% 50.5% 
Double 32 31.7% 82.2% 
Triple 12 11.9% 94.1% 
Multiple 6 5.9% 100.0% 




excluding single infections. When single infections were 
included in estimating the multiplicity of infection, an 
average multiplicity of 1.78 infections per patient was 
obtained. Pure 3D7 allelic family genotypes were 
detected in 39 (38.6%) of all genotypes detected (n = 
101). Twenty-six (25.7%) of samples carried purely FC27 
allelic family genotypes. About 36 (35.6%) carried mixed 
alleles of these two allelic families. In summary, we 
detected about 20 different alleles of the 3D7-type and 16 
different FC27-type alleles in this study. The alleles occu- 
 




rred as single or mixed with another or other alleles within 
and between families pinpointing marked parasite 
diversity. 
Since this was a longitudinal study, restriction digestion 
was also done on 15 follow-up samples in an attempt to 
detect recrudescent or new infections.  These samples 
had parasitaemia either at day 3 (D3), day 7 (D7), day 14 
(D14) or in all these days of follow up. No DNA fragments 
were determined in two samples. Presumably, three 
samples had restriction fragment patterns on D3, D7 and 
D14 similar to respective D0 samples despite one of 
them missing similar restriction fragments on D7. One 
sample had similar RFLP fragments on D3 and D14 
which were different from D0 fragments but none on D7. 
Another sample had detectable RFLP digests only on D0 
but not in the rest of follow up days. There was also a 
sample that had similar D0 and D3 restriction fragment 
patterns belonging to 3D7 allelic family but in the 
subsequent two follow up days, double infections were 
detected one belonging to either of the two MSP2 allelic 
families. In this sample the original allelic family persisted 
with a new one belonging to the FC27 allelic family 
emerging. Another sample had baseline single infection 
similar to D3 and D7 belonging to 3D7 allelic family but 
D14 had a different infection belonging to FC27 allelic 
family. Two samples had similar restriction fragment 
patterns belonging to FC27 allelic family but none was 
detectable on the rest of follow up samples (D7 and D14). 
Restriction digestion analysis also showed existence of a 
single infection of 3D7-type in D0 and D3 in two samples 
but none could be detected on D7 and D14 samples. 
Another sample had triple infections two of 3D7-type and 
one of FC27 allelic family detectable at D0. In this 
sample, one of 3D7 allele was not detected on D3 but 
two, each belonging to either of the two allelic families. 
D7 sample possessed all triple infections detected at D0. 
No infection was detectable on D14. One sample 
harboured a single 3D7-type allele on D0; none could be 
detected on D3 and D7 and in D14, a single infection 





The 141 infants aged less than five years recruited in this 
study, represent the age group most vulnerable to 
falciparum malaria (WHO, 2003). Clinical data reflected 
treatment failure in 10.6% of patients.  This group of 
patients who successfully completed the study could 
have been possessing either recrudescent parasites or 
new infections by D14. We therefore used the clinical 
observations as a base for planning molecular studies on 
the causal-outcome relationship regarding SP treatment 
in follow up samples in children from Mlimba. The 
treatment failures observed in this study were probably 
attributable to parasite resistance to SP. This was 





Parasite recurrence in SP treated individuals has been 
linked to many factors (Felger et al., 1999). Such factors 
include overwhelmed immunity, multiple concurrent 
infections and drug resistance. In this study detection of 
polymorphisms in both the MSP2 and the drug target 
genes were done in accordance to Felger et al. (1999) 
and Duraisingh et al. (1998), respectively. Primers used 
in this study have been used by Foley et al. (1992) and 
Felger et al. (1993) and are stipulated in ‘The Guidelines 
for Protocols Involving Molecular Markers of Drug 
Resistance and Multiplicity of Infections’ part IV 
(MIM/TDR, 2001) that was adopted in this study. The 
standard protocol can also be obtained from 
http://www.nlm.nih.gov/adrn/sop_molecular_markers.pdf. 
To obtain desirable fragment containing the region 
responsible for polymorphisms in the MSP2 gene, the 
primers S2/S3 and S1/S4 were used as primary and 
nested primers, respectively. These primers have been 
developed to amplify the 5' and 3' conserved region 
immediately flanking the central polymorphic part of the 
MSP2 gene (Felger et al., 1999) and produce DNA 
fragments varying from 378 bp to 740 bp (Figures 1 and 
2). The PCR amplification success was high (88.7%) and 
the PCR failures (11.3%) are probably attributable to low 
parasitaemia undetectable by PCR, microscopical errors 
(e.g. wrong determination of plasmodium species) or 
mislabelling of slides or blood samples, sequestration of 
parasites at time of sampling (Färnert et al., 1997), or due 
to point mutations at position where the MSP2-specific 
primers anneal (Kassberger et al., 2002) thus impairing 
successful results.  
HinfI digestion of PCR amplicons produces restriction 
fragments, distinguishing the 3D7 from FC27 allelic 
families of MSP2 gene. Separation of the RFLP digests 
was done on 10% polyacrylamide gel. The frequency of 
different MSP2 allelic families of P. falciparum in children 
from Mlimba was found to be high in this study. About 51 
(50.5%) out of 101 infants carried single infection of 
either of the two allelic families (3D7 and FC27). Double 
infection was observed in 32 (31.7%) of the infants, 12 
(11.9%) infants carried triple infection and 6 (5.9%) had 
multiple infections. The number of concurrent genotype 
per blood sample (multiplicity of infection) in this study 
showed up to 6 infections per patient with only two 
patients harbouring six infections per blood sample. 
About 50 (49.5%) of patients harboured 2 – 6 infections, 
leading to an average of 2.58 infections per patient. This 
was slightly lower than the multiplicity of 3.2 – 3.4 per 
patient previously reported by Babiker et al. (1999) in 
samples collected from patients in Michenga, a village 
along Kilombero valley which is endemic to the disease 
like Mlimba. However, in contrast to that study, multiple 
infections were found in nearly 50% of the patients in 
Mlimba when compared with 85% obtained in Michenga. 
When single infections were included in estimations of 
multiplicity of infections, an average multiplicity of 1.78 






average each sampled infant in Mlimba division had at 
least two infections at the time when blood sample was 
collected.   
In many areas, the parasite population changes with 
time and season. Babiker et al. (1999) reported 
differences in multiplicity of infection between areas with 
seasonal transmission and those with stable transmission 
(endemic areas), the multiplicity being higher in the latter 
due to genetic recombination. Felger et al. (1999) 
observed that all PCR products representing 
recombination between the 3D7 and FC27 allelic families 
contained family-specific 36 and 96 bp repeats which 
were classified as FC27. These fragments were detected 
in this study, even though at low level (19.8%) and were 
classified as FC27 alleles. In addition, the large 
proportion of infants with single infection lowered the 
overall multiplicity of infection in this study when included 
in the analysis. Multiplicity of infections is also dependent 
on the typing method and age group of patients from 
which the blood samples are obtained. Beck et al. (1997) 
and Smith et al. (1999) reported a higher load of infection 
among children aged between 1 – 9 years old with 
multiple infections of about  5 clones per patient. 
However in  another study conducted in the same area 
by Felger et al. (1999) revealed an average of 2.1 clones 
among infants, which is close to what was obtained in 
this study (average of 1.78 clones per infection). 
In regard to individual allelic families, this study showed 
that 75 (74.3%) sampled infants carried 3D7 allelic family 
in which 57 (56.4%), 14 (13.9%), 3 (3.0%) and 1 (1.0%) 
of the parasite occurred as single, double, triple and 
quintuple infections of the respective allelic family (Table 
2). The FC27 allelic family occurred in 62 (61.4%) 
patients in which 47 (46.7%), 12 (11.9%), 2 (2.0%) and 1 
(1.0%) were single, double, triple and quadruple 
infections, respectively.  This shows that, of the two 
polymorphic MSP2 gene allelic families, the 3D7 was 
more prevalent in the study population than the FC27. 
The composition of alleles in each family in this study 
was however, similar to that reported by Felger et al. 
(1999) who conducted a similar study in the Kilombero 
valley along which Mlimba is situated. This shows that 
the parasite population in this area might have become 
stable which may be attributable to endemicity of the 
disease in the area resulting to frequent cross-mating 
between parasites. This is important in disease 
intervention studies as it allows clones with novel 
genotypes to be produced, bringing together genes, 
which additively generate phenotypes such as multiple 
drug-resistances (Babiker et al., 1999).  
Allelic diversity in the MSP2 gene detected in this study 
was high with 20 different 3D7 family alleles and 16 
different FC27 family alleles observed. This indicates 
that, at the MSP2 gene, 3D7 and FC27 alleles were 
nearly equally distributed (ratio = 5/4). More or less 
similar results were reported by Smith et al. (1999) in 
Namawala, another area lying along the northern edge of 




flood plains of the Kilombero River. 
Data from follow up samples showed that some alleles 
either transiently disappeared or additional alleles 
appeared and eventually disappeared again in some 
samples during follow up. This observation has been 
reported by Aubouy et al. (2003) in Sudan. In the present 
study, similar RFLP fragment patterns were observed 
from samples collected from D0 to D14 in three patients 
during follow up even though one of the samples had no 
RFLP digests on D7. The re-occurrence of similar 
fragments in these three samples may be coupled with a 
recrudescing parasite. However infection with a new 
clone of similar genotype is not uncommon in a stable 
parasite population due to cross-mating as was reported 
in previous studies by Babiker et al. (1999). The absence 
of restriction digests in one sample on D7 might be due to 
absence of parasite DNA sample possibly accounted with 
low parasitaemia following medication. In multiple 
infections, the most abundant allele in the blood sample 
suppresses amplification of an allele, which is less 
abundant (Contamin et al., 1995). The variable RFLP 
digests in the rest of follow up samples could be 
attributable to the exposure of infants to parasite clones 
with inconsistent susceptibility to SP in endemic areas. In 
this context, the patients are probably intermittently 
infected and re-infected with P. falciparum strains 
possessing different sensitivity to the drug constantly 
circulating between hosts in the parasite population.  
In conclusion, our findings showed that the marker 
genes selected were suitable for use in this study. The 
malaria parasites in Mlimba were highly polymorphic and 
diverse due to high number of different alleles detected in 
MSP2 allelic families. In addition, genotyping of these 
genes enabled establishment of multiplicity of infections 
and level of recrudescence in the study area. However, 
from this study we could not rule out that clonal 
disappearance during follow up was the result of 
treatment activity, and its reappearance due to re-
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